Janssen’s Ponvory Will Face Stiff Competition In Europe’s MS Market
Approved In The EU For RMS
Janssen is the latest big pharma company to gain an approval for a new oral multiple sclerosis therapy in the EU, enhancing the competitiveness of the marketplace, and giving more choice for patients.
